|
1
|
Madurga A, Miziková I, Ruiz-Camp J and
Morty RE: Recent advances in late lung development and the
pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell
Mol Physiol. 305:L893–L905. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pietrzyk JJ, Kwinta P, Wollen EJ,
Bik-Multanowski M, Madetko-Talowska A, Günther CC, Jagła M, Tomasik
T and Saugstad OD: Gene expression profiling in preterm infants:
New aspects of bronchopulmonary dysplasia development. PLoS One.
8:e785852013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warburton D, Bellusci S, De Langhe S, Del
Moral PM, Fleury V, Mailleux A, Tefft D, Unbekandt M, Wang K and
Shi W: Molecular mechanisms of early lung specification and
branching morphogenesis. Pediatr Res. 57:R26–R37. 2005. View Article : Google Scholar
|
|
4
|
Thébaud B: Angiogenesis in lung
development, injury and repair: Implications for chronic lung
disease of prematurity. Neonatology. 91:291–297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rojas M, Xu J, Woods CR, Mora AL, Spears
W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem
cells in repair of the injured lung. Am J Respir Cell Mol Biol.
33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yam J, Frank L and Roberts RJ: Oxygen
toxicity: Comparison of lung biochemical responses in neonatal and
adult rats. Pediatr Res. 12:115–119. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mei SH, McCarter SD, Deng Y, Parker CH,
Liles WC and Stewart DJ: Prevention of LPS-induced acute lung
injury in mice by mesenchymal stem cells overexpressing
angiopoietin 1. PLoS Med. 4:e2692007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ortiz LA, Gambelli F, McBride C, Gaupp D,
Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell
engraftment in lung is enhanced in response to bleomycin exposure
and ameliorates its fibrotic effects. Proc Natl Acad Sci USA.
100:8407–8411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu J, Woods CR, Mora AL, Joodi R, Brigham
KL, Iyer S and Rojas M: Prevention of endotoxin-induced systemic
response by bone marrow-derived mesenchymal stem cells in mice. Am
J Physiol Lung Cell Mol Physiol. 293:L131–L141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aslam M, Baveja R, Liang OD,
Fernandez-Gonzalez A, Lee C, Mitsialis SA and Kourembanas S: Bone
marrow stromal cells attenuate lung injury in a murine model of
neonatal chronic lung disease. Am J Respir Crit Care Med.
180:1122–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Haaften T, Byrne R, Bonnet S,
Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J,
Haromy A, Eaton F, et al: Airway delivery of mesenchymal stem cells
prevents arrested alveolar growth in neonatal lung injury in rats.
Am J Respir Crit Care Med. 180:1131–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JW, Fang X, Krasnodembskaya A, Howard
JP and Matthay MA: Concise review: Mesenchymal stem cells for acute
lung injury: Role of paracrine soluble factors. Stem Cells.
29:913–919. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iosef C, Alastalo TP, Hou Y, Chen C, Adams
ES, Lyu SC, Cornfield DN and Alvira CM: Inhibiting NF-κB in the
developing lung disrupts angiogenesis and alveolarization. Am J
Physiol Lung Cell Mol Physiol. 302:L1023–L1036. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vicencio AG, Lee CG, Cho SJ, Eickelberg O,
Chuu Y, Haddad GG and Elias JA: Conditional overexpression of
bioactive transforming growth factor-beta1 in neonatal mouse lung:
A new model for bronchopulmonary dysplasia? Am J Respir Cell Mol
Biol. 31:650–656. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jelkmann W: Erythropoietin: Structure,
control of production, and function. Physiol Rev. 72:449–489.
1992.PubMed/NCBI
|
|
16
|
Lipsic E, Schoemaker RG, van der Meer P,
Voors AA, van Veldhuisen DJ and van Gilst WH: Protective effects of
erythropoietin in cardiac ischemia: From bench to bedside. J Am
Coll Cardiol. 48:2161–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
King VR, Averill SA, Hewazy D, Priestley
JV, Torup L and Michael-Titus AT: Erythropoietin and carbamylated
erythropoietin are neuroprotective following spinal cord
hemisection in the rat. Eur J Neurosci. 26:90–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang Y, Li X, Prasad PV, Xu S, Yao S, Liu
D, Yuan S and Feng D: Erythropoietin attenuates lung injury in
lipopolysaccharide treated rats. J Surg Res. 155:104–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ozer EA, Kumral A, Ozer E, Yilmaz O, Duman
N, Ozkal S, Koroglu T and Ozkan H: Effects of erythropoietin on
hyperoxic lung injury in neonatal rats. Pediatr Res. 58:38–41.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shang Y, Jiang YX, Xu SP, Wu Y, Wu ZY,
Yuan SY and Yao SL: Reduction of pulmonary inflammatory response by
erythropoietin in a rat model of endotoxaemia. Chin Med J (Engl).
122:834–838. 2009.
|
|
21
|
Zhang H, Fang J, Su H, Yang M, Lai W, Mai
Y and Wu Y: Bone marrow mesenchymal stem cells attenuate lung
inflammation of hyperoxic newborn rats. Pediatr Transplant.
16:589–599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okabe M, Ikawa M, Kominami K, Nakanishi T
and Nishimune Y: 'Green mice' as a source of ubiquitous green
cells. FEBS Lett. 407:313–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han X, Zhao L, Lu G, Ge J, Zhao Y, Zu S,
Yuan M, Liu Y, Kong F, Xiao Z and Zhao S: Improving outcomes of
acute kidney injury using mouse renal progenitor cells alone or in
combination with erythropoietin or suramin. Stem Cell Res Ther.
4:742013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balasubramaniam V, Mervis CF, Maxey AM,
Markham NE and Abman SH: Hyperoxia reduces bone marrow,
circulating, and lung endothelial progenitor cells in the
developing lung: Implications for the pathogenesis of
bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol.
292:L1073–L1084. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kunig AM, Balasubramaniam V, Markham NE,
Seedorf G, Gien J and Abman SH: Recombinant human VEGF treatment
transiently increases lung edema but enhances lung structure after
neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol.
291:L1068–L1078. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu
Z, Wang P, Zhao C and Bi J: Human umbilical cord mesenchymal stem
cell-derived neuron-like cells rescue memory deficits and reduce
amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem
Cell Res Ther. 4:762013. View
Article : Google Scholar
|
|
27
|
Zhang H, Fang J, Wu Y, Mai Y, Lai W and Su
H: Mesenchymal stem cells protect against neonatal rat hyperoxic
lung injury. Expert Opin Biol Ther. 13:817–829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tropea KA, Leder E, Aslam M, Lau AN,
Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex
Mitsialis S, Kourembanas S and Kim CF: Bronchioalveolar stem cells
increase after mesenchymal stromal cell treatment in a mouse model
of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol.
302:L829–L837. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abman SH and Matthay MA: Mesenchymal stem
cells for the prevention of bronchopulmonary dysplasia: Delivering
the secretome. Am J Respir Crit Care Med. 180:1039–1041. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hennrick KT, Keeton AG, Nanua S, Kijek TG,
Goldsmith AM, Sajjam US, Bentley JK, Lama VN, Moore BB, Schumacher
RE, et al: Lung cells from neonates show a mesenchymal stem cell
phenotype. Am J Respir Crit Care Med. 175:1158–1164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krause DS, Theise ND, Collector MI,
Henegariu O, Hwang S, Gardner R, Neutzel S and Sharkis SJ:
Multi-organ, multi-lineage engraftment by a single bone
marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wen ST, Chen W, Chen HL, Lai CW, Yen CC,
Lee KH, Wu SC and Chen CM: Amniotic fluid stem cells from EGFP
transgenic mice attenuate hyperoxia-induced acute lung injury. PLoS
One. 8:e753832013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gore AV, Bible LE, Livingston DH, Mohr AM
and Sifri ZC: Mesenchymal stem cells enhance lung recovery after
injury, shock, and chronic stress. Surgery. 159:1430–1435. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitsialis SA and Kourembanas S: Stem
cell-based therapies for the newborn lung and brain: Possibilities
and challenges. Semin Perinatol. 40:138–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luan Y, Zhang X, Kong F, Cheng GH, Qi TG
and Zhang ZH: Mesenchymal stem cell prevention of vascular
remodeling in high flow-induced pulmonary hypertension through a
paracrine mechanism. Int Immunopharmacol. 14:432–437. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Buckley S and Warburton D: Dynamics of
metalloproteinase-2 and -9, TGF-beta, and uPA activities during
normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol
Physiol. 283:L747–L754. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ekekezie II, Thibeault DW, Simon SD,
Norberg M, Merrill JD, Ballard RA, Ballard PL and Truog WE: Low
levels of tissue inhibitors of metalloproteinases with a high
matrix metallopro-teinase-9/tissue inhibitor of metalloproteinase-1
ratio are present in tracheal aspirate fluids of infants who
develop chronic lung disease. Pediatrics. 113:1709–1714. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harijith A, Choo-Wing R, Cataltepe S,
Yasumatsu R, Aghai ZH, Janér J, Andersson S, Homer RJ and Bhandari
V: A role for matrix metalloproteinase 9 in IFNγ-mediated injury in
developing lungs: Relevance to bronchopulmonary dysplasia. Am J
Respir Cell Mol Biol. 44:621–630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Abman SH: Impaired vascular endothelial
growth factor signaling in the pathogenesis of neonatal pulmonary
vascular disease. Adv Exp Med Biol. 661:323–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
De Paepe ME, Mao Q, Powell J, Rubin SE,
DeKoninck P, Appel N, Dixon M and Gundogan F: Growth of pulmonary
microvasculature in ventilated preterm infants. Am J Respir Crit
Care Med. 173:204–211. 2006. View Article : Google Scholar
|
|
42
|
Maniscalco WM, Watkins RH, Pryhuber GS,
Bhatt A, Shea C and Huyck H: Angiogenic factors and alveolar
vasculature: Development and alterations by injury in very
premature baboons. Am J Physiol Lung Cell Mol Physiol.
282:L811–L823. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hosford GE and Olson DM: Effects of
hyperoxia on VEGF, its receptors and HIF-2 in the newborn rat lung.
Am J Physiol Lung Cell Mol Physiol. 285:L161–L168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Acarregui MJ, Penisten ST, Goss KL,
Ramirez K and Snyder JM: Vascular endothelial growth factor gene
expression in human fetal lung in vitro. Am J Respir Cell Mol Biol.
20:14–23. 1999. View Article : Google Scholar
|
|
45
|
Le Cras TD, Markham NE, Tuder RM, Voelkel
NF and Abman SH: Treatment of newborn rats with a VEGF receptor
inhibitor causes pulmonary hypertension and abnormal lung
structure. Am J Physiol Lung Cell Mol Physiol. 283:L555–L562. 2002.
View Article : Google Scholar : PubMed/NCBI
|
